Breaking News Instant updates and real-time market news.

ATRS

Antares Pharma

$3.11

-0.01 (-0.32%)

07:26
08/08/17
08/08
07:26
08/08/17
07:26

Antares Pharma reports Q2 EPS (2c), consensus (3c)

Reports Q2 revenue $13.4M, consensus $12.51M.

  • 08

    Aug

  • 26

    Sep

  • 20

    Oct

ATRS Antares Pharma
$3.11

-0.01 (-0.32%)

03/31/17
JEFF
03/31/17
NO CHANGE
JEFF
Jefferies doubles Antares price target to $6 from $3
Jefferies analyst Anthony Petrone doubled this price target on shares of Antares Pharma to $6 from $3. The stock in early trading is up 7c to $2.81. In a research note today to investors, Petrone said his thesis on the company continues to be that its pipeline is well positioned to see a "succession of positive catalysts" over the next 24 months. Five pipeline products through 2019 collectively address $8B in new market opportunities, Petrone contends. He sees potential share upside to $15 with successful product launches "overtime." The FDA action date for Quickshot Testosterone, Antares' sub-Q testosterone replacement therapy, is October 20, 2017. Based on a "strong" clinical profile, the analyst assumes QST can capture 50% from existing brands or 15% of the total market.
04/20/17
RAJA
04/20/17
INITIATION
Target $4.3
RAJA
Strong Buy
Antares Pharma initiated with a Strong Buy at Raymond James
Raymond James analyst Elliot Wilbur initiated Antares Pharma with a Strong Buy and a $4.30 price target telling investors its business model diversity provides management with multiple value creation levers by playing in the generics arena targeting the $70B U.S. auto-injector and pre-filled syringe market, serving as life-cycle extension partner for branded assets facing end of life crisis or capturing full economic value of self-developed proprietary drugs.
05/10/17
JEFF
05/10/17
NO CHANGE
Target $6
JEFF
Buy
Jefferies sees Antares shares getting to $15 over time
Jefferies analyst Anthony Petrone views Antares Pharma's Q1 report as "solid" ahead of a "catalyst rich" second half of 2017. The better than expected results reflect continued strength in Sumatriptan device sales to Teva (TEVA) and a rebound in Otrexup, Petrone tells investors in a post-earnings research note. He believes four new products can win clearance in the second half of the year. Petrone sees the stock getting to $15 over time on successful launches from current pipeline products and keeps a Buy rating on Antares with a $6 price target. The stock in afternoon trading is down 4% to $2.67.
06/23/17
HCWC
06/23/17
INITIATION
Target $5
HCWC
Buy
Antares Pharma initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Corey Davis initiated Antares Pharma with a Buy and a $5 price target saying he sees further upside as its diversified business strategy finally matures in the near future. The analyst said Antares is a sum-of-the-parts story, and we believe several of those parts could come into clarity within months, including potential 3Q17 A/B-rated generic EpiPen approval, Antares' own Xyosted testosterone PDUFA date, Oct. 2017, partnered generic Byetta approval/launch, and partnered Makena auto injector Oct. 2017 PDUFA. Davis expects cash flow to breakeven in second half 2018, profitability in 2019, and said sum-of-the parts valuation results in a $5 price target.

TODAY'S FREE FLY STORIES

IBTX

Independent Bank

$67.05

(0.00%)

, GBNK

Guaranty Bancorp

$29.95

(0.00%)

14:25
09/25/18
09/25
14:25
09/25/18
14:25
Conference/Events
Guaranty Bancorp to host special shareholder meeting »

Special Shareholder…

IBTX

Independent Bank

$67.05

(0.00%)

GBNK

Guaranty Bancorp

$29.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

14:20
09/25/18
09/25
14:20
09/25/18
14:20
General news
FOMC began its 2-day meeting and will announce its decision at 14 ET Wednesday »

FOMC began its 2-day…

CRM

Salesforce

$158.62

-0.235 (-0.15%)

, AAPL

Apple

$222.01

1.22 (0.55%)

14:19
09/25/18
09/25
14:19
09/25/18
14:19
Hot Stocks
Salesforce Co-CEO Benioff says 'economy is still ripping' »

Marc Benioff is being…

CRM

Salesforce

$158.62

-0.235 (-0.15%)

AAPL

Apple

$222.01

1.22 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/25/18
09/25
14:17
09/25/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/25/18
09/25
14:16
09/25/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$3.47

0.175 (5.31%)

14:10
09/25/18
09/25
14:10
09/25/18
14:10
Options
5-strike call buyers in Antares Pharma and implied volatility spikes »

5-strike call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

FB

Facebook

$165.12

-0.285 (-0.17%)

14:06
09/25/18
09/25
14:06
09/25/18
14:06
Periodicals
Facebook likely to pick Adam Mosseri to head Instagram, The Information says »

Facebook will likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

PAYX

Paychex

$73.06

-1.5 (-2.01%)

, ADP

ADP

$147.62

-1.5 (-1.01%)

14:04
09/25/18
09/25
14:04
09/25/18
14:04
Recommendations
Paychex, ADP, Square analyst commentary  »

New Square payroll app…

PAYX

Paychex

$73.06

-1.5 (-2.01%)

ADP

ADP

$147.62

-1.5 (-1.01%)

SQ

Square

$94.22

8.16 (9.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 11

    Oct

  • 22

    Oct

  • 31

    Oct

  • 26

    Nov

NTES

NetEase

$214.55

4.41 (2.10%)

14:00
09/25/18
09/25
14:00
09/25/18
14:00
Upgrade
NetEase rating change  »

Follow-up: NetEase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$147.41

-1.71 (-1.15%)

13:55
09/25/18
09/25
13:55
09/25/18
13:55
Options
ADP put volume heavy and directionally bearish »

Bearish flow noted in ADP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

GTS

Triple-S

$20.33

-0.7 (-3.33%)

13:50
09/25/18
09/25
13:50
09/25/18
13:50
Hot Stocks
Triple-S finalizes contract with Government of Puerto Rico on Medicaid plan »

Triple-S Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

NTES

NetEase

$214.61

4.47 (2.13%)

13:47
09/25/18
09/25
13:47
09/25/18
13:47
Upgrade
NetEase rating change  »

NetEase upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.29

5.41 (3.06%)

, GOOG

Alphabet

$1,184.00

10.62 (0.91%)

13:46
09/25/18
09/25
13:46
09/25/18
13:46
Periodicals
Spotify asks EU for stronger regulations against U.S. rivals, Reuters reports »

Driven by concerns over…

SPOT

Spotify

$182.29

5.41 (3.06%)

GOOG

Alphabet

$1,184.00

10.62 (0.91%)

GOOGL

Alphabet Class A

$1,192.91

13.13 (1.11%)

AMZN

Amazon.com

$1,957.44

22.94 (1.19%)

EBAY

eBay

$32.72

-1 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

HIMX

Himax

$5.87

-0.03 (-0.51%)

13:45
09/25/18
09/25
13:45
09/25/18
13:45
Options
Himax call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
09/25/18
09/25
13:45
09/25/18
13:45
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

SHOP

Shopify

$163.33

1.06 (0.65%)

, AMZN

Amazon.com

$1,957.00

22.5 (1.16%)

13:43
09/25/18
09/25
13:43
09/25/18
13:43
Periodicals
Shopify CEO welcomes competition from Amazon, Bloomberg reports »

Shopify's (SHOP) CEO…

SHOP

Shopify

$163.33

1.06 (0.65%)

AMZN

Amazon.com

$1,957.00

22.5 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 13

    Nov

CHRS

Coherus Biosciences

$16.35

0.3 (1.87%)

13:40
09/25/18
09/25
13:40
09/25/18
13:40
Hot Stocks
Coherus Biosciences receives European Commission approval for UDENYCA »

Coherus BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Nov

LMT

Lockheed Martin

$344.92

7.27 (2.15%)

13:36
09/25/18
09/25
13:36
09/25/18
13:36
Hot Stocks
U.S. Army awards Lockheed Martin $289M HIMARS contract »

The U.S. Army awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KMX

CarMax

$76.31

0.43 (0.57%)

13:35
09/25/18
09/25
13:35
09/25/18
13:35
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

NKE

Nike

$84.97

0.7 (0.83%)

, CTAS

Cintas

$211.87

0.69 (0.33%)

13:35
09/25/18
09/25
13:35
09/25/18
13:35
Earnings
Notable companies reporting after market close »

Notable companies…

NKE

Nike

$84.97

0.7 (0.83%)

CTAS

Cintas

$211.87

0.69 (0.33%)

KBH

KB Home

$25.53

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

JBL

Jabil

$27.43

-2.65 (-8.81%)

, CLS

Celestica

$10.72

-0.14 (-1.29%)

13:35
09/25/18
09/25
13:35
09/25/18
13:35
Hot Stocks
Jabil falls after CEO commentary on margin and expansion, peers also fall »

Shares of companies…

JBL

Jabil

$27.43

-2.65 (-8.81%)

CLS

Celestica

$10.72

-0.14 (-1.29%)

SANM

Sanmina

$28.40

-0.9 (-3.07%)

FLEX

Flex

$12.97

-0.33 (-2.48%)

XLNX

Xilinx

$77.89

-1.26 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 01

    Oct

  • 09

    Oct

  • 13

    Nov

13:32
09/25/18
09/25
13:32
09/25/18
13:32
Conference/Events
JPMorgan Euro software analysts to hold an analyst/industry conference call »

European Software &…

T

AT&T

$33.95

0.04 (0.12%)

13:31
09/25/18
09/25
13:31
09/25/18
13:31
Periodicals
AT&T CEO wants more HBO content over next three years, Variety reports »

AT&T CEO Randall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 24

    Oct

  • 06

    Nov

  • 12

    Nov

XLV

Health Care Select Sector SPDR

$94.41

-0.01 (-0.01%)

13:30
09/25/18
09/25
13:30
09/25/18
13:30
Options
Large hedge in the SPDR Healthcare Fund »

Large hedge in the SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$94.08

0.64 (0.68%)

, VRTX

Vertex

$182.97

0.69 (0.38%)

13:26
09/25/18
09/25
13:26
09/25/18
13:26
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.08

0.64 (0.68%)

VRTX

Vertex

$182.97

0.69 (0.38%)

ACER

Acer Therapeutics

$30.56

0.86 (2.90%)

BHVN

Biohaven Pharmaceutical

$36.71

0.37 (1.02%)

CELG

Celgene

$88.17

0.6 (0.69%)

EXEL

Exelixis

$17.11

0.24 (1.42%)

PTLA

Portola Pharmaceuticals

$27.54

0.38 (1.40%)

BMY

Bristol-Myers

$62.23

0.65 (1.06%)

BIIB

Biogen

$344.09

-2.89 (-0.83%)

AMGN

Amgen

$207.98

0.68 (0.33%)

BLUE

Bluebird Bio

$142.65

3.1 (2.22%)

ONCE

Spark Therapeutics

$56.21

0.19 (0.34%)

LOXO

Loxo Oncology

$163.72

0.65 (0.40%)

RCKT

Rocket Pharmaceuticals

$25.44

0.67 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.